Anthony Letai, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Anthony Letai, Dana-Farber Cancer Institute

Caption

Anthony Letai, MD, PhD, and colleagues from Dana-Farber Cancer Institute have devised a test that can predict how effective chemotherapy drugs will be in treating a cancer by determining whether tumor cells are already "primed" for death.

Credit

Sam Ogden, Dana-Farber

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.